ID CCNA2_BOVIN Reviewed; 430 AA. AC P30274; Q17QS7; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 17-OCT-2006, sequence version 2. DT 24-JAN-2024, entry version 170. DE RecName: Full=Cyclin-A2 {ECO:0000305}; DE Short=Cyclin-A {ECO:0000303|PubMed:1333843}; GN Name=CCNA2 {ECO:0000250|UniProtKB:P20248}; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=Hereford; TISSUE=Thalamus; RG NIH - Mammalian Gene Collection (MGC) project; RL Submitted (JUN-2006) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] OF 24-430. RC TISSUE=Lymphocyte; RX PubMed=1333843; DOI=10.1091/mbc.3.11.1279; RA Kobayashi H., Stewart E., Poon R., Adamczewski J.P., Gannon J., Hunt T.; RT "Identification of the domains in cyclin A required for binding to, and RT activation of, p34cdc2 and p32cdk2 protein kinase subunits."; RL Mol. Biol. Cell 3:1279-1294(1992). RN [3] RP X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 179-430. RX PubMed=8591034; DOI=10.1016/s0969-2126(01)00259-3; RA Brown N.R., Noble M.E.M., Endicott J.A., Garman E.F., Wakatsuki S., RA Mitchell E., Rasmussen B., Hunt T., Johnson L.N.; RT "The crystal structure of cyclin A."; RL Structure 3:1235-1247(1995). CC -!- FUNCTION: Cyclin which controls both the G1/S and the G2/M transition CC phases of the cell cycle. Functions through the formation of specific CC serine/threonine kinase holoenzyme complexes with the cyclin-dependent CC protein kinases CDK1 and CDK2. The cyclin subunit confers the substrate CC specificity of these complexes and differentially interacts with and CC activates CDK1 and CDK2 throughout the cell cycle. CC {ECO:0000250|UniProtKB:P20248}. CC -!- SUBUNIT: Interacts with the CDK1 and CDK2 protein kinases to form CC serine/threonine kinase holoenzyme complexes. Interacts with CDK1 CC (hyperphosphorylated form in G1 and underphosphorylated forms in S and CC G2). Interacts with CDK2; the interaction increases from G1 to G2. CC Interacts (associated with CDK2 but not with CDK1) with SCAPER; CC regulates the activity of CCNA2/CDK2 by transiently maintaining CCNA2 CC in the cytoplasm. Forms a ternary complex with CDK2 and CDKN1B; CDKN1B CC inhibits the kinase activity of CDK2 through conformational CC rearrangements. Interacts with INCA1. {ECO:0000250|UniProtKB:P20248}. CC -!- INTERACTION: CC P30274; P24941: CDK2; Xeno; NbExp=2; IntAct=EBI-15688654, EBI-375096; CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P20248}. Cytoplasm CC {ECO:0000250|UniProtKB:P20248}. Note=Exclusively nuclear during CC interphase. Detected in the nucleus and the cytoplasm at prophase. CC Cytoplasmic when associated with SCAPER. CC {ECO:0000250|UniProtKB:P20248}. CC -!- PTM: Polyubiquitinated via 'Lys-11'-linked ubiquitin by the anaphase- CC promoting complex (APC/C), leading to its degradation by the CC proteasome. Deubiquitinated and stabilized by USP37 enables entry into CC S phase. {ECO:0000250|UniProtKB:P20248}. CC -!- SIMILARITY: Belongs to the cyclin family. Cyclin AB subfamily. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BC118203; AAI18204.1; -; mRNA. DR EMBL; X68321; CAA48398.1; -; mRNA. DR PIR; S24788; S24788. DR RefSeq; NP_001068591.1; NM_001075123.1. DR PDB; 1VIN; X-ray; 2.00 A; A=170-429. DR PDB; 2G9X; X-ray; 2.50 A; B/D=170-430. DR PDB; 3BHT; X-ray; 2.00 A; B/D=169-430. DR PDB; 3BHU; X-ray; 2.30 A; B/D=169-430. DR PDB; 3BHV; X-ray; 2.10 A; B/D=169-430. DR PDB; 3DDP; X-ray; 2.70 A; B/D=169-430. DR PDB; 3DDQ; X-ray; 1.80 A; B/D=169-430. DR PDB; 3DOG; X-ray; 2.70 A; B/D=169-430. DR PDB; 3MY5; X-ray; 2.10 A; B/D=169-430. DR PDB; 3TNW; X-ray; 2.00 A; B/D=169-430. DR PDB; 4BCN; X-ray; 2.10 A; D=169-430. DR PDB; 4BCO; X-ray; 2.05 A; B/D=169-429. DR PDB; 4BCQ; X-ray; 2.40 A; B=169-429, D=169-430. DR PDB; 6GUB; X-ray; 2.52 A; B/D=170-430. DR PDB; 6GUC; X-ray; 2.00 A; B/D=170-430. DR PDB; 6GUE; X-ray; 1.99 A; B/D=169-430. DR PDB; 6GUF; X-ray; 2.65 A; B/D=170-430. DR PDBsum; 1VIN; -. DR PDBsum; 2G9X; -. DR PDBsum; 3BHT; -. DR PDBsum; 3BHU; -. DR PDBsum; 3BHV; -. DR PDBsum; 3DDP; -. DR PDBsum; 3DDQ; -. DR PDBsum; 3DOG; -. DR PDBsum; 3MY5; -. DR PDBsum; 3TNW; -. DR PDBsum; 4BCN; -. DR PDBsum; 4BCO; -. DR PDBsum; 4BCQ; -. DR PDBsum; 6GUB; -. DR PDBsum; 6GUC; -. DR PDBsum; 6GUE; -. DR PDBsum; 6GUF; -. DR AlphaFoldDB; P30274; -. DR SMR; P30274; -. DR BioGRID; 158986; 5. DR DIP; DIP-693N; -. DR IntAct; P30274; 3. DR STRING; 9913.ENSBTAP00000006503; -. DR BindingDB; P30274; -. DR ChEMBL; CHEMBL4106153; -. DR PaxDb; 9913-ENSBTAP00000006503; -. DR GeneID; 281667; -. DR KEGG; bta:281667; -. DR CTD; 890; -. DR eggNOG; KOG0654; Eukaryota. DR HOGENOM; CLU_020695_3_2_1; -. DR InParanoid; P30274; -. DR OrthoDB; 5474295at2759; -. DR EvolutionaryTrace; P30274; -. DR Proteomes; UP000009136; Unplaced. DR GO; GO:0097124; C:cyclin A2-CDK2 complex; IBA:GO_Central. DR GO; GO:0000307; C:cyclin-dependent protein kinase holoenzyme complex; ISS:UniProtKB. DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB. DR GO; GO:0005634; C:nucleus; ISS:AgBase. DR GO; GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IBA:GO_Central. DR GO; GO:0044843; P:cell cycle G1/S phase transition; ISS:UniProtKB. DR GO; GO:0051301; P:cell division; IEA:UniProtKB-KW. DR GO; GO:0000086; P:G2/M transition of mitotic cell cycle; ISS:UniProtKB. DR GO; GO:0044772; P:mitotic cell cycle phase transition; IBA:GO_Central. DR GO; GO:0006275; P:regulation of DNA replication; ISS:UniProtKB. DR CDD; cd20561; CYCLIN_CCNA2_rpt1; 1. DR CDD; cd20564; CYCLIN_CCNA2_rpt2; 1. DR Gene3D; 1.10.472.10; Cyclin-like; 2. DR InterPro; IPR039361; Cyclin. DR InterPro; IPR032447; Cyclin-A_N. DR InterPro; IPR013763; Cyclin-like_dom. DR InterPro; IPR036915; Cyclin-like_sf. DR InterPro; IPR046965; Cyclin_A/B-like. DR InterPro; IPR004367; Cyclin_C-dom. DR InterPro; IPR006671; Cyclin_N. DR InterPro; IPR048258; Cyclins_cyclin-box. DR PANTHER; PTHR10177:SF444; CYCLIN-A2; 1. DR PANTHER; PTHR10177; CYCLINS; 1. DR Pfam; PF02984; Cyclin_C; 1. DR Pfam; PF00134; Cyclin_N; 1. DR Pfam; PF16500; Cyclin_N2; 1. DR PIRSF; PIRSF001771; Cyclin_A_B_D_E; 1. DR SMART; SM00385; CYCLIN; 2. DR SMART; SM01332; Cyclin_C; 1. DR SUPFAM; SSF47954; Cyclin-like; 2. DR PROSITE; PS00292; CYCLINS; 1. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Cell cycle; Cell division; Cyclin; Cytoplasm; KW Mitosis; Nucleus; Phosphoprotein; Reference proteome; Ubl conjugation. FT CHAIN 1..430 FT /note="Cyclin-A2" FT /id="PRO_0000080337" FT REGION 1..80 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 106..129 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 16..38 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 106..121 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 1 FT /note="N-acetylmethionine" FT /evidence="ECO:0000250|UniProtKB:P20248" FT MOD_RES 5 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P20248" FT CONFLICT 24 FT /note="A -> E (in Ref. 2; CAA48398)" FT /evidence="ECO:0000305" FT CONFLICT 107 FT /note="Missing (in Ref. 2; CAA48398)" FT /evidence="ECO:0000305" FT HELIX 170..172 FT /evidence="ECO:0007829|PDB:3DDQ" FT TURN 174..176 FT /evidence="ECO:0007829|PDB:3DDQ" FT HELIX 177..190 FT /evidence="ECO:0007829|PDB:3DDQ" FT TURN 195..197 FT /evidence="ECO:0007829|PDB:3BHV" FT HELIX 198..200 FT /evidence="ECO:0007829|PDB:3DDQ" FT HELIX 206..222 FT /evidence="ECO:0007829|PDB:3DDQ" FT HELIX 227..243 FT /evidence="ECO:0007829|PDB:3DDQ" FT HELIX 248..250 FT /evidence="ECO:0007829|PDB:3DDQ" FT HELIX 251..266 FT /evidence="ECO:0007829|PDB:3DDQ" FT HELIX 273..279 FT /evidence="ECO:0007829|PDB:3DDQ" FT TURN 280..282 FT /evidence="ECO:0007829|PDB:3DDQ" FT HELIX 286..299 FT /evidence="ECO:0007829|PDB:3DDQ" FT TURN 300..302 FT /evidence="ECO:0007829|PDB:3DDQ" FT HELIX 309..317 FT /evidence="ECO:0007829|PDB:3DDQ" FT STRAND 320..322 FT /evidence="ECO:0007829|PDB:1VIN" FT HELIX 325..340 FT /evidence="ECO:0007829|PDB:3DDQ" FT HELIX 342..345 FT /evidence="ECO:0007829|PDB:3DDQ" FT HELIX 350..366 FT /evidence="ECO:0007829|PDB:3DDQ" FT HELIX 372..378 FT /evidence="ECO:0007829|PDB:3DDQ" FT HELIX 382..398 FT /evidence="ECO:0007829|PDB:3DDQ" FT HELIX 399..401 FT /evidence="ECO:0007829|PDB:3DDQ" FT HELIX 406..410 FT /evidence="ECO:0007829|PDB:3DDQ" FT HELIX 414..416 FT /evidence="ECO:0007829|PDB:3DDQ" FT HELIX 419..421 FT /evidence="ECO:0007829|PDB:3DDQ" SQ SEQUENCE 430 AA; 48262 MW; FACA1B8E770E997F CRC64; MLGSSAHGPA AREAGSAVTL QQTAFQEDQE NVNPEKAAPA QQPRTRAGLA VLRAGNSRGP APQRPKTRRV APLKDLPIND EYVPVPPWKA NNKQPAFTIH VDEAEEEIQK RPTESKKSES EDVLAFNSAV TLPGPRKPLA PLDYPMDGSF ESPHTMEMSV VLEDEKPVSV NEVPDYHEDI HTYLREMEVK CKPKVGYMKK QPDITNSMRA ILVDWLVEVG EEYKLQNETL HLAVNYIDRF LSSMSVLRGK LQLVGTAAML LASKFEEIYP PEVAEFVYIT DDTYTKKQVL RMEHLVLKVL AFDLAAPTIN QFLTQYFLHQ QPANCKVESL AMFLGELSLI DADPYLKYLP SVIAAAAFHL ALYTVTGQSW PESLVQKTGY TLETLKPCLL DLHQTYLRAP QHAQQSIREK YKNSKYHGVS LLNPPETLNV //